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ABSTRACT
Background: with easier access to life saving antiretroviral drugs, children with 
HIV/AIDS now have better life expectancy  and  informing them of their status 
has become of exceeding  importance.
Objectives: this study set to assess the age at which HIV infected children 
attending the Paediatric HIV care and treatment clinic of the Federal medical 
centre Owerri, were informed of their status.
Methods: the study was cross sectional in nature and carried out over six months 
between February and July 2010. Parents/Care providers of HIV infected 
children were interviewed using a purpose created questionnaire. Information on 
age and other socio-demographic features of the patient and diagnosis disclosure 
status were obtained.
Results: Sixty Parents / Care providers of HIV infected children were 
interviewed.10 (16.7%) children have had their status disclosed to them.  
6(60%) had disclosure at age 11-13years, 3(30%) had disclosure at 8-10years 
and only 1(10%) child had diagnosis disclosed at less than 8years of age. The 
inability of the child to fully understand and comprehend the meaning of HIV 
infection was the commonest reason for non disclosure. Other reasons were the 
child's inability to keep the diagnosis secret and the belief that the information 
would depress the child.
Conclusion: the diagnosis disclosure rate in our study was low and this could 
impact negatively on outcome. This is so because diagnosis disclosure has been 
shown to enhance adherence to treatment and coping strategies. 
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Âge à la divulgation de l'infection à VIH parmi  les enfants fréquentant 
de pédiatrie  soins et au traitement du VIH centre à Owerri, sud-est du 
Nigéria.
Nwolisa CE, Mbanefo FN and Ezeogu J
Rapport court
RÉSUMÉ
Antécédents: with plus facile accès à sauver la vie médicaments antirétroviraux, 
les enfants vivant avec le VIH/SIDA vivent maintenant plus longtemps et la 
divulgation du statut VIH d'enfants infectés est de plus en plus important.
Objectifs: tson étude défini pour évaluer l'âge à  la divulgation du diagnostic de 
l'infection à VIH parmi les enfants fréquentant un soins pédiatriques   et centre 
de traitement à Owerri, sud-est du Nigéria.
Sujets/méthodes: til étude transversale par nature et réalisée entre février et 
juillet 2010 dans la pédiatrie soins et au traitement du VIH clinique du fédéral, du 
centre médical Owerri. Les parents et les dispensateurs de soins des enfants 
infectés par le VIH ont été interrogés à l'aide d'un questionnaire structuré. 
Informations sur les caractéristiques socio-démographiques caractéristiques du 
patient et le diagnostic divulgation statut ont été obtenus .
Résultats : 60 Parents / fournisseurs de soins des enfants infectés par le VIH 
étaient interviewed.10 ( 16,7 %), les enfants ont eu leur statut qui leur sont 
communiqués. 6 (60%) avaient la divulgation à l'âge de 11-13ans , 3 (30 %) 
divulgation avait à 8-10ans et seulement1 (10 %) enfant diagnostic avait 
divulgué à moins de 8 ans. La raison la plus commune pour non-divulgation a été 
l'incapacité de l'enfant à comprendre le sens de l'infection par le VIH. D'autres 
raisons ont été l'enfant est dans l'incapacité de conserver le diagnostic secret et 
cette conviction que l'information serait enfoncer l'enfant.
Conclusion: til diagnostic taux de divulgation dans notre étude était faible et 
cela pourrait avoir un impact négatif sur les résultats. Il en est ainsi parce que le 
diagnostic la divulgation a été montré pour améliorer l'observance du traitement 
et des stratégies d'adaptation. 
Mots clés. Le VIH, le diagnostic, la divulgation, le résultat.
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INTRODUCTION
In the earlier years of the HIV/AIDS 
pandemic, infection in children in most 
resource poor countries of sub Sahara Africa 
tended to result in poor outcomes (1). With 
increasing availability of counseling and 
testing centers, the opportunity for easier 
access to testing and subsequent early 
diagnosis became possible. These centers 
with the assistance of implementing/donor 
partners helped to increase access to life 
saving antiretroviral drugs (2). The resultant 
effect is that children with HIV/AIDS in 
these countries now have better life 
expectancy and disclosing their HIV status to 
them has become exceedingly important. 
Informing a child of his/her HIV 
status has numerous well documented (3-4) 
challenges bordering on the child, the 
parents/caregivers and even the health 
personnel. Diagnosis disclosure should 
amongst others   take cognizance of the 
child's age, mental maturity and family 
related issues.
Informing the child of the diagnosis 
of HIV infection is not a one off event but a 
process involving multiple visits. It has been 
advocated that disclosure be done at school 
a g e  a n d  s h o u l d  i n v o l v e  t h e  
parents/caregivers and knowledgeable 
professionals (5).
Diagnosis disclosure has tremendous 
advantages which include better adherence, 
increased ability to cope with challenges 
brought about by the infection as well as 
reduction of negative psychosocial impacts 
of the disease and reduction of risk of 
infecting others (6-7). The children have 
been noticed following disclosure to become 
better able to understand the disease and the 
periodic health challenges they might 
intermittently face and the benefit of 
adhering to their drugs (8).
In spite of these advantages, there is 
s t i l l  i n t e n s e  r e l u c t a n c e  a m o n g s t  
parents/caregivers and health professional in 
disclosing a diagnosis of HIV/AIDS (9-10). 
Numerous reasons have been adduced and 
they appear to be similar in spite of economic 
and socio cultural differing status and 
scenarios (11-14).
In Nigeria, there is still a paucity of 
studies documenting the age at disclosure 
and the factors associated with it. This study 
set to document the age at which HIV 
infection status was disclosed to children 
attending the Paediatric HIV care and 
treatment clinic of Federal Medical Centre 
Owerri, South Eastern Nigeria.  
METHODS
The Federal Medical Centre, Owerri 
is a tertiary health facility providing multi 
disciplinary medical services to clients from 
Imo state and surrounding states of Abia, 
Anambra and Rivers. The hospital has a 
Heart to Heart centre which is supported by 
Family health international through the 
GHAIN project. The centre provides 
comprehensive HIV care and treatment to 
both adults and children. 
Study design.
The study was cross sectional in 
nature and was carried out in six months 
between February and July 2010. All 
consenting parents and care providers of HIV 
Infected children who were attending the 
clinic during the study period were eligible 
but only those whose children or wards were 
5 years of age and above were enrolled. 
During the six month study period, 60 
parents/care givers who met the criteria for 
inclusion and gave consent and were 
consequently included in the study.
Interviews
Parents/care providers of the patients 
were interviewed using a purpose developed 
questionnaire. The questionnaire elicited 
information on the age, socio- demographic 
details of the children and their HIV infection 
disclosure status.
Data analysis
Analysis following the interview was 
done using the Statistical Package SPSS 
Version 15.
Ethical clearance/issues
The ethical committee of the Federal 
Medical Centre, Owerri gave ethical 
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clearance for this study. Verbal consent was 
also sought and received from the parents or 
care providers before the interview.
RESULT
Sample description
Sixty parents/care providers were 
interviewed in the course of the study. They 
consisted of42 (70%) biological parents, 9 
(15%) grandmothers and 9 (15%) other 
relatives. The children were 24 (40%) males 
and 36 (60%) females with an age range of 5 – 
16years. 26 (43.3%) were between 5 and 
7years, 16 (26.7%) between 8 and 10years, 
11 (23.4%) between 11 and 13years and 7 
(16.6%) between 14 and 16years.
Disclosure status
Ten children (16.7%) had been told 
and knew they were HIV positive. They 
consisted of 2 (20%) males and 8 (80%) 
females.  Ages at disclosure were 3(30%) 
children at age 9, 4(40%) at age 11 and 3 
(30%) at age 12. 50 (83.3%) children had not 
been told and did not know they were HIV 
Positive. Amongst these, intended age for 
disclosure by either the parent or care 
provider was: Age less than 10years 1(2%), 
between 10 and 15years 41(82%) and above 
15years 8(16%) - Table 2.
Reasons for non disclosure of HIV 
diagnosis
A total of 78% of the children whose 
diagnosis had not been disclosed were as a 
result of their perceived inability to 
understand the diagnosis by their  
parents/care providers. The other reasons for 
non disclosure of diagnosis are shown in 
Table 1.
DISCUSSION
The HIV diagnosis disclosure rate in 
our study was 16.7%. Though higher, it is still 
in tandem with 13.5% reported in an earlier 
study in Ibadan, South western Nigeria (11), 
14% in an Indian study (12) and 17.4% from 
Addis Ababa (15).  A Thai study reported 
19.8% while a study in Ghana reported21% 
(8). These low levels from our study and that 
from similar resource poor countries fit into 
the lower range of the 18%-77% reported 
from studies in resource rich countries (16). It 
has been suggested that these low levels 
could be linked to lack or paucity of a defined 
method or guild line targeted at teaching or 
aiding disclosure in children (8). This 
suggestion holds true for our study because as 
at when we interviewed the parents/care 
givers, no HIV disclosure manual or guild 
line had been issued locally. The World 
health organization produced one in 2011 
(17) and   it does not appear as yet to have 
been adapted for use in Nigeria. 
The low diagnosis disclosure rate in 
our study would appear to suggest that most 
of our patients were receiving drugs without 
knowing what the drugs were for and why. 
This could potentially increase the risk of 
poor adherence, drug resistance and 
treatment failure. One of the attendant effects 
would be a negation of anticipated gains and 
better outcomes expected from early 
initiations and more readily availability of 
anti retroviral drugs.
Most of children in our study had 
their diagnosis disclosed at age of ten years 
and above. Most parents/care providers who 
had not disclosed, intended to ,when the child 
would have become   ten  years  of age or 
older. This agrees with report from several 
other studies (11, 12, 14). Notably, both 
parents/care-providers in our study who had 
disclosed the diagnosis of HIV and those who 
had not, believe that beyond age ten the child 
would be in a better position or better able to 
understand the diagnosis of HIV and also be 
more likely in their opinion to keep the 
information secret because of the perceived 
stigma associated with the infection.
The commonest reason given in our 
study for not disclosing the diagnosis of HIV 
was that the child would not understand what 
HIV infection meant. This has also   been 
reported and documented by several other 
studies (12-14). It would appear from these 
reports that in spite of cultural and religious 
differences, the thought that the child would 
not understand the implication of HIV   
remains the most significant reason for non 
disclosure of diagnosis. 
Of note though, is the finding that the 
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more intelligent the child was as manifested 
by a higher IQ and the more expressive the 
family was increased the probability of 
earlier diagnostic disclosure to HIV-infected 
children (18). Parents/caregiver's HIV status 
has also been shown to impact significantly 
on disclosure of diagnosis to the child 
(19) .Unfortunately this  cannot  be 
extrapolated from our study because we did 
not seek for the HIV status of parent/care 
giver during the course of our interview.
    While various children-related 
reasons were given in our study for not 
disclosing the diagnosis, a South African 
study that assessed care givers barriers to 
disclosure found that while considering 
disclosure an important desire was the 
protect ion of  their  chi ldren from 
discrimination, social rejection, and pain 
(20).  The resultant effect of these was the 
attendant non disclosure of diagnosis.
Our study did not assess the effect of 
disclosing diagnosis on adherence to 
antiretroviral drugs but several studies have 
documented that disclosure impacted 
positively on drug adherence, sexual 
behavior and general outlook (21).
We conclude that in spite of the 
numerous advantages and positive impacts of 
diagnosis disclosure, most of the children 
attending our HIV care and treatment centre 
were still ignorant of their HIV status and this 
potentially could affect adherence with its 
attendant deleterious effect on treatment 
outcome.
We recommend that the now 
available WHO manual for diagnosis 
disclosure be urgently adapted for local use in 
Nigerian and included in the Nigerian 
national guild line for providing care and 
treatment for children living with HIV and 
AIDS.  
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